enVVeno Medical effects 1:35 reverse stock split, shares outstanding drop to ~655,606

enVVeno Medical Corp

Reverse split ratio 1:35 effective Jan 20, 2026; no fractional shares issued, rounded up.
Outstanding shares reduced from 22,946,223 to 655,606; authorized shares unchanged at 250M.
Proportional adjustments made to stock options and warrants (e.g., exercise price increased 35x).
Common stock began trading on split-adjusted basis Jan 20, 2026; transfer agent Equiniti managing exchange.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

enVVeno Medical Corp: One-for-thirty-five reverse stock split effected by filing Certificate of Amendment to Fifth Amended and Restated Certificate of Incorporation (effective 2026-01-20).

Change: charter amendment
Effective: 2026-01-20

Exact text from the filing

To effect the Reverse Stock Split, the Company filed with the Delaware Secretary of State a Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation of the Company (the “Certificate of Amendment”) which became effective as of 12:01 a.m. Eastern Standard Time on Tuesday, January 20, 2026.

View on SEC.gov

84 governance changes filed in the last 30 days. Browse all governance changes →

enVVeno Medical Corp filing history →

Source: SEC EDGAR

accession 0001493152-26-002860

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.